Lara-Reyna J, Chae J, Tosi U, Souweidane MM, Uribe-Cardenas R, Greenfield JP.
2020.
Syringomyelia Resolution Following Chiari Surgery: A Novel Scale for Communication and Research.. Neurosurgery. 88(1):E60-E66.
A Wernicke G, Lazow SP, Taube S, Yondorf MZ, Kovanlikaya I, Nori D, Christos P, Boockvar JA, Pannullo S, Stieg PE et al..
2016.
Surgical Technique and Clinically Relevant Resection Cavity Dynamics Following Implantation of Cesium-131 (Cs-131) Brachytherapy in Patients With Brain Metastases.. Oper Neurosurg (Hagerstown). 12(1):49-60.
Aleem IS, Tan LA, Nassr A, K Riew D.
2020.
Surgical Site Infection Prevention Following Spine Surgery.. Global Spine J. 10(1 Suppl):92S-98S.
Bander ED, Kocharian G, Liechty B, Tsiouris AJ, Schwartz TH.
2020.
Spontaneous regression of a clival chordoma. Case report.. Acta Neurochir (Wien). 162(2):433-436.
Oshima Y, Kelly MP, Song K-S, Park MSoo, Chuntarapas T, Vo KD, Yeom JS, Takeshita K, K Riew D.
2016.
Spinolaminar Line Test as a Screening Tool for C1 Stenosis.. Global Spine J. 6(4):370-4.
Tundo F, Avila MJ, Willard L, Fanous S, Curri C, Hussain I, Baaj AA.
2019.
Spinal alignment, surgery, and outcomes in cervical deformity: A practical guide to aid the spine surgeon. Clin Neurol Neurosurg. 185:105496.
Younus I, Gerges MM, Uribe-Cardenas R, Morgenstern P, Kacker A, Tabaee A, Anand VK, Schwartz TH.
2020.
The slope of the learning curve in 600 consecutive endoscopic transsphenoidal pituitary surgeries.. Acta Neurochir (Wien). 162(10):2361-2370.
Yerneni K, Burke JF, Chunduru P, Molinaro AM, K Riew D, Traynelis VC, Tan LA.
2020.
Safety of Outpatient Anterior Cervical Discectomy and Fusion: A Systematic Review and Meta-Analysis.. Neurosurgery. 86(1):30-45.
Yerneni K, Burke JF, Chunduru P, Molinaro AM, K Riew D, Traynelis VC, Tan LA.
2020.
Safety of Outpatient Anterior Cervical Discectomy and Fusion: A Systematic Review and Meta-Analysis.. Neurosurgery. 86(1):30-45.
Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA, Bland RJ, Young D, Strybing K, Eidelberg D et al..
2007.
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet. 369(9579):2097-105.